G13/NL2 is a modern, hybrid-indica strain bred from the lineage of G-13 x Northern Lights #2 F-1 Hybrid crossed with Northern Lights #2. This genetic pairing highlights a focus on stable, high-yield traits suitable for both indoor and outdoor cultivation. Plants of this variety reach maturity after a flowering period of 65 days and are categorized as moderate in terms of cultivation difficulty, offering growers a high-yield potential when managed correctly. The strain has since established a genetic footprint in the industry, having been used to produce notable offspring such as G13/NL2 x NL5.

The terpene profile of G13/NL2 is defined by myrcene as its dominant aromatic compound, followed by secondary notes of caryophyllene and tertiary hints of pinene. This combination shapes the sensory profile of the flower, rooting the bouquet in the earthy, musky foundation of myrcene before transitioning into the spicy, peppery undertones contributed by caryophyllene and a subtle, pine-forward finish. As a THC-dominant variety, the chemistry of this strain is engineered to balance these aromatic nuances with the potency expected of its hybrid-indica classification.

Regarding physical and mental utility, G13/NL2 is sought after for its capacity to induce states of relaxation, calmness, and focus. These effects make the strain a functional choice for users managing pain, stress, or those seeking support for sleep. According to lore, this strain is recognized for its utility in medicinal applications due to the reliable consistency of its cannabinoid expression. By successfully transmitting its hardy traits to later generations, G13/NL2 remains a relevant parent variety for contemporary breeding projects focused on hybrid vigour and therapeutic efficacy.